AMP Capital Investors’s Amphastar Pharmaceuticals AMPH Stock Holding History

AMP Capital Investors’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,500	Closed	-$202K	–	1141
2019 Q4	$202K	Hold	10,500	–	–	﹤0.01%	1141
2019 Q3	$212K	Buy	+10,500	New	+$219K	﹤0.01%	1131
2016 Q1	–	Sell	-21,814	Closed	-$312K	–	1183
2015 Q4	$312K	Buy	21,814 +3,672	+20%	+$48.5K	﹤0.01%	1069
2015 Q3	$196K	Buy	+18,142	New	+$272K	﹤0.01%	1129

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

AMP Capital Investors's AMPH Position: Q1 2020 in Review

AMP Capital Investors sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2020, closing a stake of 10,500 shares — an estimated $202K sold.

AMP Capital Investors first reported a position in AMPH in Q3 2015 and held it in 4 quarters. The position peaked at $312K in Q4 2015. 111 funds tracked by Wall St. Rank hold AMPH as of Q1 2020.

AMP Capital Investors reported no remaining Amphastar Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
AMP Capital Investors sold 10,500 Amphastar Pharmaceuticals shares in Q1 2020, an estimated $202K.
AMP Capital Investors first reported a position in Amphastar Pharmaceuticals in Q3 2015 and held it in 4 quarters.
AMP Capital Investors's Amphastar Pharmaceuticals position peaked at $312K in Q4 2015.
111 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2020.

Based on AMP Capital Investors's 13F filing for Q1 2020, filed 13 May 2020.